Conclusion

Author(s):  
Marc Humbert

Pulmonary hypertension is a fast-growing field in cardiopulmonary medicine. Thanks to recent advances summarized in the 2015 European Society of Cardiology/European Respiratory Society guidelines, evidence-based pulmonary hypertension management can now be provided to all pulmonary hypertension patients. There are, however, important gaps of evidence which should be clarified in future work.

ESC CardioMed ◽  
2018 ◽  
pp. 2562-2564
Author(s):  
Marc Humbert

Pulmonary hypertension is a fast-growing field in cardiopulmonary medicine. Thanks to recent advances summarized in the 2015 European Society of Cardiology/European Respiratory Society guidelines, evidence-based pulmonary hypertension management can now be provided to all pulmonary hypertension patients. There are, however, important gaps of evidence which should be clarified in future work.


ESC CardioMed ◽  
2018 ◽  
pp. 2502-2506
Author(s):  
Adam Torbicki

Echocardiography provides clinically important information in suspected and confirmed cases of pulmonary hypertension. By assessing the probability of pulmonary hypertension and contributing to prognostic evaluation of patients at baseline and during follow-up, echocardiography has gained an important place in both diagnostic and therapeutic algorithms recommended by current European Society of Cardiology/European Respiratory Society guidelines.


VASA ◽  
2011 ◽  
Vol 40 (1) ◽  
pp. 6-19 ◽  
Author(s):  
Klein-Weigel ◽  
Opitz ◽  
Riemekasten

Due to its high association with Raynaud’s phenomenon systemic sclerosis (SSc) is probably the most common connective tissue disease seen by vascular specialists. In part 1 of our systematic overview we summarize classification concepts of scleroderma disorders, the epidemiologic and genetic burden, the complex pathophysiologic background, and the clinical features and the stage-dependent capillary microscopic features of SSc. Furthermore, we address the diagnostic recommendations propagated by the German Network for Systemic Sclerosis and the Task Force for Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology, the European Respiratory Society, and the International Society of Heart and Lung Transplantation.


Sign in / Sign up

Export Citation Format

Share Document